Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer
Conditions: Colorectal Cancer; Appendiceal Cancer; Peritoneal Carcinoma Interventions: Drug: Oxaliplatin; Drug: mFOLFIRI Sponsor: University of Utah Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Appendix Cancer | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Eloxatin | Peritoneal Cancer | Research